House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase
In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH
ACS Initiates Cage In Approach to Study Of alternative Methods
DT Board Oks RFAs In Surgery, HIV, Breast Cancer
Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala
FDA Simplifies Reporting Of Adverse Events
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG